BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21455721)

  • 1. Glomerular pathology in Alport syndrome: a molecular perspective.
    Cosgrove D
    Pediatr Nephrol; 2012 Jun; 27(6):885-90. PubMed ID: 21455721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell-specific collagen type IV-α
    Funk SD; Bayer RH; Miner JH
    Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.
    Cosgrove D; Liu S
    Matrix Biol; 2017 Jan; 57-58():45-54. PubMed ID: 27576055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
    Kashtan CE
    Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.
    Heidet L; Cai Y; Guicharnaud L; Antignac C; Gubler MC
    Am J Pathol; 2000 Jun; 156(6):1901-10. PubMed ID: 10854213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
    Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
    Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity of a Human Laminin
    Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
    J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.
    Korstanje R; Caputo CR; Doty RA; Cook SA; Bronson RT; Davisson MT; Miner JH
    Kidney Int; 2014 Jun; 85(6):1461-8. PubMed ID: 24522496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
    Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
    Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
    Zhang Y; Ding J
    Pediatr Nephrol; 2018 Aug; 33(8):1309-1316. PubMed ID: 28864840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
    Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
    Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hematuria: A review.
    Plevová P; Gut J; Janda J
    Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants.
    Liapis H; Gökden N; Hmiel P; Miner JH
    Hum Pathol; 2002 Aug; 33(8):836-45. PubMed ID: 12203217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the pathomechanisms and future therapies of Alport syndrome.
    Noone D; Licht C
    Pediatr Nephrol; 2013 Jul; 28(7):1025-36. PubMed ID: 22903660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.